Medindia3d
Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study
Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...
Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50% CAGR - Credence Research
The Global Microplates Market is experiencing steady growth, driven by the increasing adoption of high-throughput screening ...